Orgametril (Lynestrenol)

Orgametril contains Lynestrenol, a synthetic progestogen that acts within the hormonal contraceptive pathway.

• Contraception: prevents pregnancy by suppressing ovulation and inducing endometrial changes that inhibit implantation.

• Lynestrenol binds to progesterone receptors in the hypothalamus and pituitary, reducing the secretion of gonadotropins (LH and FSH). This inhibition blocks follicular development and ovulation. In the uterus, it promotes secretory transformation of the endometrium, creating an environment unsuitable for implantation, thereby providing contraceptive efficacy.

Lynestrenol may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: tension‑type or migraine‑like pain.
• Breast tenderness: discomfort or swelling of the breasts.
• Weight gain: modest increase in body weight.
• Mood changes: irritability or emotional lability.
• Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects

• Thromboembolic events: deep‑vein thrombosis or pulmonary embolism.
• Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
• Liver dysfunction: jaundice, elevated liver enzymes.
• Depression: persistent low mood or suicidal thoughts.
• Visual disturbances: blurred vision or eye pain.
• Cardiovascular hypertension: sudden rise in blood pressure.

Before initiating therapy with Orgametril, several safety considerations are recommended.

• Thromboembolism risk: assess personal or family history of clotting disorders.
• Liver function: evaluate hepatic health, especially in patients with known liver disease.
• Blood pressure: monitor for hypertension, particularly in smokers.
• Smoking status: advise cessation, as smoking increases cardiovascular risk.
• Medication review: check for concomitant drugs that may reduce efficacy.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lynestrenol can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Rifampicin and other strong enzyme inducers: may markedly reduce contraceptive efficacy.
• Anticonvulsants (e.g., carbamazepine, phenytoin): can lower plasma levels of Lynestrenol.
• Protease inhibitors (e.g., ritonavir): may decrease hormonal activity.
• St. John’s wort: herbal inducer that diminishes contraceptive effect.
• Certain antiretrovirals: may compromise hormonal control.

Moderate Interactions (Monitor Closely)

• Azole antifungals (ketoconazole, itraconazole): can increase Lynestrenol concentrations.
• Macrolide antibiotics (erythromycin, clarithromycin): may modestly raise hormone levels.
• SSRIs (fluoxetine, sertraline): potential for altered menstrual bleeding patterns.
• Antihypertensives (beta‑blockers): monitor blood pressure changes.
• Herbal supplements (ginseng): observe for any reduction in contraceptive reliability.